Ibex Wealth Advisors Sells 2,362 Shares of CME Group Inc. $CME

Ibex Wealth Advisors reduced its holdings in CME Group Inc. (NASDAQ:CME) by 6.6% during the third quarter, Holdings Channel.com reports. The institutional investor owned 33,166 shares of the financial services provider’s stock after selling 2,362 shares during the quarter. CME Group accounts for about 0.9% of Ibex Wealth Advisors’ investment portfolio, making the stock its 28th largest holding. Ibex Wealth Advisors’ holdings in CME Group were worth $8,961,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Caldwell Trust Co increased its position in CME Group by 116.3% during the 3rd quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 50 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new position in shares of CME Group during the third quarter valued at about $27,000. Financial Consulate Inc. bought a new position in CME Group in the third quarter worth about $28,000. Sagard Holdings Management Inc. purchased a new stake in CME Group in the second quarter worth about $30,000. Finally, Corundum Trust Company INC purchased a new position in shares of CME Group during the 3rd quarter worth approximately $30,000. Institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other CME Group news, Director Dennis Suskind sold 748 shares of the firm’s stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $300.00, for a total transaction of $224,400.00. Following the completion of the transaction, the director owned 2,699 shares in the company, valued at $809,700. This trade represents a 21.70% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $305.90, for a total transaction of $91,770.00. Following the completion of the sale, the director owned 24,999 shares in the company, valued at approximately $7,647,194.10. This trade represents a 1.19% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 30,248 shares of company stock valued at $8,355,450. 0.30% of the stock is currently owned by corporate insiders.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME reported record 2025 results: $6.5B in revenue, AD volume rose 6% to 28.1M contracts (commodities +12%, financials +5%), highlighting continued franchise growth and fee-related revenue strength. This earnings strength is the primary bullish catalyst. CME Group (CME) Achieves Record 2025 Results with $6.5B in Revenue
• Positive Sentiment: CME expanded physical-market infrastructure by approving the first aluminium warehousing facility in Taiwan, supporting commodities product growth and global market access for metals. That strengthens long-term fees and product diversification. CME approves first aluminium warehousing in Taiwan
• Neutral Sentiment: Intraday data and flow reports show mixed signals: QuiverQuant flagged heavy volume and both insider selling and sizable institutional position changes (some managers added, some trimmed). This suggests active rebalancing rather than a clear directional bet. $CME stock is up 2% today. Here’s what we see in our data.
• Neutral Sentiment: Reported short-interest data in the feed appears anomalous (zeros/NaN). No clear short-pressure signal is evident from that entry, so it shouldn’t be driving meaningful price moves. (Treat as data glitch/unreliable.)
• Negative Sentiment: CME experienced a brief technical glitch that halted metals and natural gas trading on Globex and briefly pressured the stock when markets reacted; trading was subsequently restarted. Operational reliability concerns can weigh on near-term sentiment until fully resolved. CME Group halts metals and natural gas trading on technical issues
• Negative Sentiment: Commentary criticizing CME’s Variable Storage Rate program (commodity storage economics) may pressure sentiment among some commodities market participants; impact is likely niche but could attract headlines. Why I Hate Variable Storage Rates

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on CME shares. Morgan Stanley upped their price target on CME Group from $319.00 to $340.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Jefferies Financial Group reduced their price target on shares of CME Group from $304.00 to $302.00 and set a “buy” rating for the company in a research note on Monday, January 12th. JPMorgan Chase & Co. raised their target price on shares of CME Group from $262.00 to $266.00 and gave the stock an “underweight” rating in a report on Thursday, February 5th. Rothschild & Co Redburn upped their price objective on CME Group from $300.00 to $333.00 and gave the company a “neutral” rating in a research report on Thursday, February 12th. Finally, UBS Group reissued a “neutral” rating and issued a $310.00 target price on shares of CME Group in a research report on Friday, February 6th. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus price target of $299.53.

CME Group Price Performance

Shares of CME Group stock opened at $319.50 on Friday. The stock has a market cap of $115.21 billion, a P/E ratio of 28.63, a P/E/G ratio of 3.70 and a beta of 0.27. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.03. The stock’s fifty day moving average is $287.63 and its 200 day moving average is $275.97. CME Group Inc. has a one year low of $248.53 and a one year high of $322.57.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, topping the consensus estimate of $2.75 by $0.02. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.64 billion. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter last year, the company earned $2.52 earnings per share. Sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 26th. Investors of record on Tuesday, March 10th will be issued a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, March 10th. This represents a $5.20 annualized dividend and a yield of 1.6%. This is an increase from CME Group’s previous quarterly dividend of $1.25. CME Group’s payout ratio is currently 44.80%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.